{"id":"cox2-inhibitor-celecoxib","safety":{"commonSideEffects":[{"rate":"5-10","effect":"Hypertension"},{"rate":"5-8","effect":"Dyspepsia"},{"rate":"4-6","effect":"Abdominal pain"},{"rate":"3-5","effect":"Diarrhea"},{"rate":"3-5","effect":"Headache"},{"rate":"1-2","effect":"Cardiovascular events (myocardial infarction, stroke)"}]},"_chembl":{"chemblId":"CHEMBL118","moleculeType":"Small molecule","molecularWeight":"381.38"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"COX-2 is an inducible enzyme responsible for generating pro-inflammatory prostaglandins at sites of inflammation. By selectively blocking COX-2 while sparing COX-1, celecoxib reduces inflammation and pain with potentially fewer gastrointestinal side effects than non-selective NSAIDs. This selectivity makes it useful for chronic inflammatory conditions while theoretically preserving the protective functions of COX-1-derived prostaglandins in the stomach and kidneys.","oneSentence":"Celecoxib selectively inhibits cyclooxygenase-2 (COX-2), reducing the production of prostaglandins that mediate inflammation and pain.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:31:19.126Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Rheumatoid arthritis"},{"name":"Osteoarthritis"},{"name":"Acute pain"},{"name":"Ankylosing spondylitis"},{"name":"Familial adenomatous polyposis (FAP)"}]},"trialDetails":[{"nctId":"NCT06076837","phase":"PHASE1","title":"The Seven Trial: Exploiting the Unfolded Protein Response","status":"ACTIVE_NOT_RECRUITING","sponsor":"HonorHealth Research Institute","startDate":"2025-01-09","conditions":"Pancreatic Cancer Metastatic, Pancreatic Adenocarcinoma Metastatic","enrollment":6},{"nctId":"NCT07246278","phase":"PHASE1, PHASE2","title":"Celecoxib in Parkinson Disease as Adjuvant Therapy","status":"RECRUITING","sponsor":"Tanta University","startDate":"2025-11-20","conditions":"Parkinson Disease","enrollment":80},{"nctId":"NCT03912428","phase":"PHASE1","title":"Novel PET Radioligand as an Inflammatory Biomarker in Musculoskeletal Conditions","status":"TERMINATED","sponsor":"National Institute of Mental Health (NIMH)","startDate":"2019-06-14","conditions":"Myositis, Inflammatory, Rheumatoid Arthritis","enrollment":31},{"nctId":"NCT07154316","phase":"PHASE2","title":"Phase II RCT of LCRT vs SCRT + CAPOX/PD-1i/COX-2i in MSS Locally Advanced Rectal Cancer","status":"RECRUITING","sponsor":"Fudan University","startDate":"2025-08-01","conditions":"Colorectal Cancer","enrollment":138},{"nctId":"NCT07150949","phase":"PHASE2","title":"Long-course Chemoradiotherapy or Short-course Radiotherapy Combined With CAPOX, PD-1antibody, and COX-2 Inhibitor for MSS Locally Advanced Rectal Cancer (SERRAC)","status":"RECRUITING","sponsor":"Fudan University","startDate":"2025-08-28","conditions":"Locally Advanced Rectal Cancer, Neoadjuvant Therapy","enrollment":138},{"nctId":"NCT05434065","phase":"PHASE2","title":"Effects and Mechanisms of Celecoxib on Intracerebral Hemorrhage","status":"RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2023-01-01","conditions":"Intracerebral Hemorrhage","enrollment":60},{"nctId":"NCT01479829","phase":"PHASE4","title":"Cyclooxygenase-2-Inhibitor Combination Treatment for Bipolar Depression","status":"COMPLETED","sponsor":"Loyola University","startDate":"2011-03-23","conditions":"Bipolar Depression","enrollment":100},{"nctId":"NCT04790812","phase":"PHASE4","title":"Preemptive Analgesia With Celecoxib for Acute Dental Pain Management","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2021-04-22","conditions":"Pain, Postoperative","enrollment":65},{"nctId":"NCT05578287","phase":"PHASE2","title":"RC48 Plus Tislelizumab, Low-dose Capecitabine and Celecoxib for HER2-positive Metastatic Colorectal Cancer","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2023-07-18","conditions":"Colorectal Cancer","enrollment":29},{"nctId":"NCT03638297","phase":"PHASE2","title":"PD-1 Antibody Combined With COX Inhibitor in MSI-H/dMMR or High TMB Colorectal Cancer","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2018-08-23","conditions":"Colorectal Cancer","enrollment":29},{"nctId":"NCT04673578","phase":"PHASE2","title":"Adjunctive Celecoxib in Childhood-onset OCD Study","status":"UNKNOWN","sponsor":"University of British Columbia","startDate":"2021-06-01","conditions":"Obsessive-Compulsive Disorder, Pediatric Psychiatric Disorder","enrollment":80},{"nctId":"NCT03892707","phase":"","title":"Milgamma® and Milgamma® Compositum Step-therapy in Patients With Acute Non-specific Low Back Pain Receiving Modern NSAID","status":"COMPLETED","sponsor":"Woerwag Pharma LLC","startDate":"2018-12-15","conditions":"Acute Non-specific Low Back Pain","enrollment":500},{"nctId":"NCT00663767","phase":"PHASE2","title":"A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction","status":"COMPLETED","sponsor":"Pfizer","startDate":"2008-04-07","conditions":"Dental Pain","enrollment":250},{"nctId":"NCT00075673","phase":"PHASE1","title":"Vinorelbine and Celecoxib in Treating Women With Relapsed or Metastatic Breast Cancer","status":"TERMINATED","sponsor":"Case Comprehensive Cancer Center","startDate":"2003-11","conditions":"Breast Cancer","enrollment":6},{"nctId":"NCT03896113","phase":"PHASE2","title":"Neoadjuvant Celecoxib in Newly Diagnosed Patients With Endometrial Carcinoma","status":"UNKNOWN","sponsor":"Cliniques universitaires Saint-Luc- Université Catholique de Louvain","startDate":"2019-11-13","conditions":"Endometrium Cancer","enrollment":48},{"nctId":"NCT03185871","phase":"PHASE2","title":"Celecoxib Window of Opportunity Trial to Assess Tumor and Stroma Responses","status":"WITHDRAWN","sponsor":"University of Wisconsin, Madison","startDate":"2017-09-20","conditions":"Breast Carcinoma","enrollment":""},{"nctId":"NCT01129245","phase":"NA","title":"The Effect of a Non-hormonal Cox-2 Inhibitor (Celebrex) on Ovulation","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2009-09","conditions":"Ovulation, Luteal Development","enrollment":20},{"nctId":"NCT03911570","phase":"","title":"Crystalline Glucosamine Sulfate Therapy in Hand Osteoarthritis","status":"COMPLETED","sponsor":"University of Siena","startDate":"2018-09-01","conditions":"Hand Osteoarthritis","enrollment":108},{"nctId":"NCT00061893","phase":"PHASE2","title":"Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2004-04","conditions":"Sarcoma","enrollment":38},{"nctId":"NCT03699293","phase":"PHASE4","title":"NSAIDs vs. Coxibs in the Presence of Aspirin","status":"RECRUITING","sponsor":"Inova Health Care Services","startDate":"2018-09-22","conditions":"Rheumatoid Arthritis, Cardiovascular Diseases","enrollment":30},{"nctId":"NCT03584074","phase":"PHASE4","title":"Clinical Trial of Pregabalin and COX2 in Spinal Stenosis","status":"UNKNOWN","sponsor":"Seoul National University Bundang Hospital","startDate":"2018-07-01","conditions":"Spinal Stenosis Lumbar","enrollment":60},{"nctId":"NCT00400374","phase":"PHASE1","title":"Secondary Primary Tumor Prevention With EGFR, OSI-774, and Cyclooxygenase-2","status":"COMPLETED","sponsor":"Emory University","startDate":"2007-08","conditions":"Head and Neck Cancer","enrollment":10},{"nctId":"NCT03391570","phase":"NA","title":"Comparing Postoperative Pain Following COX-2 and Prostanoids Expression","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2017-10-17","conditions":"Female Genital Disease","enrollment":60},{"nctId":"NCT00081263","phase":"PHASE2","title":"Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia","status":"COMPLETED","sponsor":"Gynecologic Oncology Group","startDate":"2005-06","conditions":"Cervical Carcinoma, Cervical Intraepithelial Neoplasia Grade 2/3, Stage 0 Cervical Cancer","enrollment":130},{"nctId":"NCT02413203","phase":"NA","title":"Lipidomics Screening of Celecoxib in ex Vivo Human Whole Blood Assay - Part B","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2015-03","conditions":"Healthy","enrollment":20},{"nctId":"NCT02711579","phase":"PHASE1","title":"Impact of Celecoxib on Electrophysiological Property in Brain of Healthy Volunteer","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2016-05","conditions":"Electrophysiologic Property of Brain","enrollment":40},{"nctId":"NCT02840162","phase":"PHASE2","title":"Pre-Prostatectomy Celecoxib or Placebo","status":"TERMINATED","sponsor":"OHSU Knight Cancer Institute","startDate":"2001-05","conditions":"Adenocarcinoma of the Prostate, Prostate Cancer","enrollment":34},{"nctId":"NCT00056082","phase":"PHASE2","title":"Celecoxib in Preventing Breast Cancer in At-Risk Premenopausal Women","status":"COMPLETED","sponsor":"University of Kansas Medical Center","startDate":"2003-01","conditions":"Breast Cancer","enrollment":110},{"nctId":"NCT00099047","phase":"PHASE2","title":"Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2004-11","conditions":"Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Smoldering Multiple Myeloma","enrollment":23},{"nctId":"NCT00450736","phase":"PHASE1","title":"Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery","status":"COMPLETED","sponsor":"University of Miami","startDate":"2004-03","conditions":"Childhood Malignant Fibrous Histiocytoma of Bone, Sarcoma","enrollment":3},{"nctId":"NCT00291694","phase":"PHASE2","title":"Protocol for Women at Increased Risk of Developing Breast Cancer","status":"COMPLETED","sponsor":"Carol Fabian, MD","startDate":"2003-04","conditions":"Breast Cancer","enrollment":72},{"nctId":"NCT01111591","phase":"PHASE4","title":"Cyclooxygenase-2 Inhibitor for Adjuvant Anticancer Effect in Patients With Biliary-pancreas Cancer","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2008-11","conditions":"Bile Duct Cancer, Pancreatic Cancer","enrollment":220},{"nctId":"NCT02850211","phase":"PHASE4","title":"A Selective COX-2 Inhibitor Provides Pain Control But Hinders Healing Following Arthroscopic Rotator Cuff Repair","status":"COMPLETED","sponsor":"Seoul National University Bundang Hospital","startDate":"2011-09","conditions":"Rotator Cuff Tear","enrollment":180},{"nctId":"NCT02790203","phase":"NA","title":"Perioperative Use of a Selective COX2 Inhibitor in Patients Undergoing Elective Colorectal Surgery: the Effect on Post-operative Bowel Motility and Post-operative Pain","status":"UNKNOWN","sponsor":"Sheba Medical Center","startDate":"2016-06","conditions":"Prevention of Post Operative Ileus","enrollment":100},{"nctId":"NCT00198081","phase":"PHASE2","title":"Use of Celecoxib in Patients With Intraductal Papillary Mucinous Neoplasms (IPMNs)","status":"TERMINATED","sponsor":"Indiana University School of Medicine","startDate":"2005-09","conditions":"Pancreas Neoplasms","enrollment":8},{"nctId":"NCT01425853","phase":"PHASE4","title":"Study on Efficacy and Safety of Chondroitin Sulfate + Glucosamine Hydrochloride Versus Celecoxib in Knee Osteoarthritis","status":"COMPLETED","sponsor":"Bioiberica","startDate":"2011-09","conditions":"Knee Osteoarthritis","enrollment":606},{"nctId":"NCT00152828","phase":"PHASE1, PHASE2","title":"Celebrex - Cervix: Celecoxib in the Treatment of Patients With Locally Advanced Carcinoma of the Cervix","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2001-02","conditions":"Cervix Neoplasms","enrollment":31},{"nctId":"NCT00046839","phase":"PHASE1, PHASE2","title":"Celecoxib and Radiation Therapy in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer","status":"COMPLETED","sponsor":"Radiation Therapy Oncology Group","startDate":"2002-07","conditions":"Lung Cancer","enrollment":21},{"nctId":"NCT00104767","phase":"PHASE1","title":"Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer","status":"COMPLETED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2009-01","conditions":"Lung Cancer","enrollment":7},{"nctId":"NCT02537925","phase":"PHASE3","title":"The Effect of COX-2 Inhibitor on Radiosensitivity in Nasopharyngeal Carcinoma","status":"UNKNOWN","sponsor":"Changjie Huang","startDate":"2014-01","conditions":"Nasopharyngeal Carcinoma","enrollment":120},{"nctId":"NCT01067989","phase":"PHASE2","title":"Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast Cancer","status":"TERMINATED","sponsor":"HaEmek Medical Center, Israel","startDate":"2010-03","conditions":"Chemotherapy, Breast Cancer, Metastatic","enrollment":22},{"nctId":"NCT00068770","phase":"PHASE2","title":"Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT","status":"TERMINATED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2003-10","conditions":"Brain and Central Nervous System Tumors","enrollment":35},{"nctId":"NCT02343614","phase":"PHASE2","title":"Celecoxib for the Treatment of Non-muscle Invasive Bladder Cancer","status":"COMPLETED","sponsor":"Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari","startDate":"2003-03","conditions":"Non Muscle Invasive Bladder Cancer","enrollment":58},{"nctId":"NCT00314262","phase":"PHASE1, PHASE2","title":"Phase I/II Study of Chemoprevention With EGFR and COX-2 Inhibitor","status":"COMPLETED","sponsor":"Emory University","startDate":"2006-10","conditions":"Precancerous Conditions","enrollment":17},{"nctId":"NCT02255006","phase":"NA","title":"Effect of Acupuncture to Endothelial Dysfunction Induced by Ischemia-reperfusion Injury","status":"UNKNOWN","sponsor":"Kyunghee University Medical Center","startDate":"2014-05","conditions":"Healthy","enrollment":36},{"nctId":"NCT01678313","phase":"PHASE2","title":"Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels","status":"COMPLETED","sponsor":"Buddhist Tzu Chi General Hospital","startDate":"2012-08","conditions":"Benign Prostatic Hyperplasia","enrollment":140},{"nctId":"NCT00023660","phase":"PHASE1, PHASE2","title":"Radiation Therapy Plus Celecoxib, Fluorouracil, and Cisplatin in Patients With Locally Advanced Cervical Cancer","status":"COMPLETED","sponsor":"Radiation Therapy Oncology Group","startDate":"2001-08","conditions":"Cervical Cancer","enrollment":84},{"nctId":"NCT00072072","phase":"PHASE1","title":"Celecoxib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer","status":"COMPLETED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2003-08","conditions":"Lung Cancer","enrollment":""},{"nctId":"NCT00101335","phase":"PHASE2","title":"Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia","status":"COMPLETED","sponsor":"Fox Chase Cancer Center","startDate":"2003-11","conditions":"Head and Neck Cancer, Precancerous Condition","enrollment":""},{"nctId":"NCT00687388","phase":"PHASE4","title":"The Clinical Efficacy of Non-steroidal Anti-inflammation Drugs in Patients With Benign Prostatic Hyperplasia","status":"WITHDRAWN","sponsor":"Samsung Medical Center","startDate":"2008-05","conditions":"Benign Prostatic Hyperplasia","enrollment":""},{"nctId":"NCT00653250","phase":"NA","title":"Celecoxib in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer","status":"COMPLETED","sponsor":"Vanderbilt-Ingram Cancer Center","startDate":"2000-12","conditions":"Lung Cancer","enrollment":22},{"nctId":"NCT00581971","phase":"PHASE1, PHASE2","title":"Radiosensitization With Celecoxib and Chemoradiation for Head and Neck Cancer","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2002-09","conditions":"Cancer","enrollment":30},{"nctId":"NCT00014404","phase":"PHASE2","title":"Celecoxib in Treating Patients With Precancerous Lesions of the Mouth","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2000-10","conditions":"Head and Neck Cancer","enrollment":""},{"nctId":"NCT00073970","phase":"PHASE2","title":"Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy","status":"TERMINATED","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2003-04","conditions":"Prostate Cancer","enrollment":37},{"nctId":"NCT00367315","phase":"PHASE3","title":"Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis (OA)","status":"COMPLETED","sponsor":"Novartis","startDate":"2003-09","conditions":"Knee Osteoarthritis","enrollment":1684},{"nctId":"NCT00231829","phase":"PHASE2","title":"A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers","status":"TERMINATED","sponsor":"Mark H. Einstein","startDate":"2003-04","conditions":"Uterine Cancer","enrollment":23},{"nctId":"NCT00442676","phase":"PHASE2","title":"Clinical Trial of a COX-2 Inhibitor for the Treatment of Women With Preeclampsia","status":"WITHDRAWN","sponsor":"Virginia Commonwealth University","startDate":"2009-06","conditions":"Preeclampsia","enrollment":""},{"nctId":"NCT00300729","phase":"PHASE3","title":"Effect of Celecoxib on Survival in Patients With Advanced Non-Small Cell Lung Cancer Receiving Chemotherapy","status":"UNKNOWN","sponsor":"University Hospital, Linkoeping","startDate":"2006-05","conditions":"Non-Small Cell Lung Cancer","enrollment":319},{"nctId":"NCT00181532","phase":"PHASE2","title":"Phase II Study of Celecoxib and Concurrent Radiotherapy in Stage II-III NSCLC","status":"COMPLETED","sponsor":"Maastricht Radiation Oncology","startDate":"2003-05","conditions":"Non Small Cell Lung Carcinoma","enrollment":102},{"nctId":"NCT00778193","phase":"PHASE4","title":"Effect of Naproxen, Aspirin, Celecoxib, or Clopidogrel on the Healing of Stomach and Intestinal Ulcers","status":"COMPLETED","sponsor":"Research Associates of New York, LLP","startDate":"2007-10","conditions":"Gastroduodenal Ulcer","enrollment":125},{"nctId":"NCT00328432","phase":"PHASE1","title":"A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/Mastectomy","status":"COMPLETED","sponsor":"University of Kansas","startDate":"2003-06","conditions":"Breast Cancer","enrollment":100},{"nctId":"NCT00001693","phase":"PHASE1","title":"Phase I-II Multiple-Dose Safety and Efficacy Study of a Selective Inhibitor of Cyclooxygenase - 2 (SC-58635) in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients and Carriers","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"1998-03","conditions":"Colorectal Neoplasm, Hereditary Nonpolyposis","enrollment":20},{"nctId":"NCT00603759","phase":"PHASE3","title":"COX-2 Inhibitor With Concurrent Chemoradiation in Locally Advanced Head & Neck Carcinoma","status":"UNKNOWN","sponsor":"Tehran University of Medical Sciences","startDate":"2006-04","conditions":"Head and Neck Cancer","enrollment":122},{"nctId":"NCT00533247","phase":"NA","title":"Arthroplasty Inflammation Prophylaxis With Celecoxib","status":"UNKNOWN","sponsor":"Zanbilowicz, Adam, DPM MS","startDate":"","conditions":"Postoperative Pain","enrollment":200},{"nctId":"NCT00365313","phase":"PHASE3","title":"Preventing Recurrent Ulcer Bleeding in Arthritis Patients Using Esomeprazole Plus Celecoxib","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2002-08","conditions":"Arthritis, Bleeding Ulcer","enrollment":273}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":40,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Celebrex"],"phase":"marketed","status":"active","brandName":"Cox2 inhibitor (Celecoxib)","genericName":"Cox2 inhibitor (Celecoxib)","companyName":"Seoul National University Hospital","companyId":"seoul-national-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Celecoxib selectively inhibits cyclooxygenase-2 (COX-2), reducing the production of prostaglandins that mediate inflammation and pain. Used for Rheumatoid arthritis, Osteoarthritis, Acute pain.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}